{"id":"NCT03237065","sponsor":"Pharmacosmos A/S","briefTitle":"Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia","officialTitle":"A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside/Ferric Derisomaltose and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (Phosphare-IDA-05)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-30","primaryCompletion":"2018-05-29","completion":"2018-05-29","firstPosted":"2017-08-02","resultsPosted":"2020-02-25","lastUpdate":"2020-02-25"},"enrollment":122,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Iron Deficiency Anaemia","Iron Deficiency Anemia"],"interventions":[{"type":"DRUG","name":"Iron isomaltoside/ferric derisomaltose","otherNames":["Monofer®, Monoferric®, Monover®, Monofar®, Monoferro®"]},{"type":"DRUG","name":"Ferric carboxymaltose","otherNames":["Injectafer®, Ferinject®"]}],"arms":[{"label":"Iron isomaltoside/ferric derisomaltose","type":"EXPERIMENTAL"},{"label":"Ferric carboxymaltose","type":"ACTIVE_COMPARATOR"}],"summary":"The trial was designed to evaluate the incidence of unintended hypophosphatemia (low level of phosphate in the blood) in subjects with iron deficiency anaemia (IDA).","primaryOutcome":{"measure":"Incidence of Hypophosphatemia (S-phosphate Level <2 mg/dL)","timeFrame":"Baseline to day 35","effectByArm":[{"arm":"Iron Isomaltoside/Ferric Derisomaltose","deltaMin":5,"sd":null},{"arm":"Ferric Carboxymaltose","deltaMin":42,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":19},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":["32016310"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":62},"commonTop":["Hypophosphatemia","Blood parathyroid hormone increased","Nausea","Blood phosphorus decreased","Headache"]}}